Gossamer Bio (GOSS) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$0.21.
- Gossamer Bio's EPS (Weighted Average and Diluted) fell 50.00% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.69, marking a year-over-year decrease of 165.38%. This contributed to the annual value of -$0.25 for FY2024, which is 78.81% up from last year.
- As of Q3 2025, Gossamer Bio's EPS (Weighted Average and Diluted) stood at -$0.21, which was down 23.53% from -$0.17 recorded in Q2 2025.
- Gossamer Bio's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.22 during Q2 2024, with a 5-year trough of -$0.76 in Q1 2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.17 (2025), whereas its average is -$0.19.
- Per our database at Business Quant, Gossamer Bio's EPS (Weighted Average and Diluted) surged by 148.89% in 2024 and then slumped by 177.27% in 2025.
- Over the past 4 years, Gossamer Bio's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.57 in 2022, then skyrocketed by 73.68% to -$0.15 in 2023, then declined by 0.00% to -$0.15 in 2024, then plummeted by 50.00% to -$0.21 in 2025.
- Its last three reported values are -$0.21 in Q3 2025, -$0.17 for Q2 2025, and -$0.16 during Q1 2025.